NCT05489341View on ClinicalTrials.gov

Artificial Intelligence and Radiologists at Prostate Cancer Detection in MRI: The PI-CAI Challenge

CompletedOBSERVATIONAL
Enrollment

10,207

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

June 1, 2023

Study Completion Date

November 1, 2023

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

Histopathology and Magnetic Resonance Imaging with Follow-Up

Reference standard establishes histologically-confirmed (ISUP ≥ 2) cases of csPCa as positives, and histopathology- (ISUP ≤ 1) or MRI- (PI-RADS ≤ 2) with follow-up (≥ 3 years) confirmed cases of indolent PCa or benign tissue as negatives.

DIAGNOSTIC_TEST

Histopathology and Magnetic Resonance Imaging

Reference standard establishes histologically-confirmed (ISUP ≥ 2) cases of csPCa as positives, and histopathology- (ISUP ≤ 1) or MRI- (PI-RADS ≤ 2) confirmed cases of indolent PCa or benign tissue as negatives.

Trial Locations (1)

6525 GA

RadboudUMC, Nijmegen

All Listed Sponsors
collaborator

Ziekenhuisgroep Twente

OTHER

collaborator

University Medical Center Groningen

OTHER

collaborator

Norwegian University of Science and Technology

OTHER

lead

Radboud University Medical Center

OTHER